An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- John Connett, PhD
University of Minnesota
Principal Investigator - Stephen Lazarus, MD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California, San Francisco-Fresno
Fresno, California, United States
- la Biomed at Harbor-Ucla Medical Center
Los Angeles, California, United States
- University of California at San Francisco
San Francisco, California, United States
- National Jewish Medical & Research Center
Denver, Colorado, United States
- North Florida/south Georgia Veterans Health System
Gainesville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Louisiana State University
New Orleans, Louisiana, United States
- University of Maryland Baltimore
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Healthpartners Research Foundation
Minneapolis, Minnesota, United States
- Veteran'S Administration Medical Center
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Newyork-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, United States
- New York Presbyterian/queens
Flushing, New York, United States
- Columbia University
New York, New York, United States
- Weill Cornell Medicine
New York, New York, United States
- Cincinnati Va Medical Center
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Temple University Lung Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Utah Health Sciences Center
Salt Lake City, Utah, United States
- the University of Vermont
Burlington, Vermont, United States
- University of Washington School of Medicine
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Jun 2020
- Primary completion
- 18 May 2022
- Completion
- 2 Dec 2022
- Last update posted
- 31 Jan 2025
- Registered enrollment
- 584
- Registry id
- NCT04717492
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.